MARKET

ADIL

ADIL

Adial Pharmaceuticals Inc
NASDAQ
0.3086
-0.0176
-5.40%
After Hours: 0.3147 +0.0061 +1.98% 18:17 12/05 EST
OPEN
0.3170
PREV CLOSE
0.3262
HIGH
0.3219
LOW
0.3038
VOLUME
238.04K
TURNOVER
--
52 WEEK HIGH
1.300
52 WEEK LOW
0.2200
MARKET CAP
7.40M
P/E (TTM)
-0.3322
1D
5D
1M
3M
1Y
5Y
1D
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement
TipRanks · 5d ago
Weekly Report: what happened at ADIL last week (1124-1128)?
Weekly Report · 6d ago
Adial Pharmaceuticals announces $2.86M warrant inducement transaction
TipRanks · 11/26 13:05
Adial Pharmaceuticals Secures $2.86M As Investor Exercises 9.2M Warrants At $0.31; Company To Issue 13.8M New Series F Warrants At Same Price
Benzinga · 11/26 13:04
ADIAL PHARMACEUTICALS ANNOUNCES A WARRANT INDUCEMENT TRANSACTION FOR APPROXIMATELY $2.86 MILLION IN GROSS PROCEEDS
Reuters · 11/26 13:00
Weekly Report: what happened at ADIL last week (1117-1121)?
Weekly Report · 11/24 10:28
Strategic Advancements and Collaborations Propel Adial Pharmaceuticals’ Buy Rating
TipRanks · 11/18 16:45
Weekly Report: what happened at ADIL last week (1110-1114)?
Weekly Report · 11/17 10:28
More
About ADIL
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.

Webull offers Adial Pharmaceuticals Inc stock information, including NASDAQ: ADIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADIL stock methods without spending real money on the virtual paper trading platform.